Journal of Medicinal Chemistry · 1998 · 44 citations · 11 references
Bioorganic ChemistryGastrointestinal PharmacologyDual CyclooxygenasePharmacotherapyNew Cyclooxygenase-2/5-lipoxygenase InhibitorsPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry5-Keto-substituted 7-Tert-butyl-2,3-dihydro-3,3-dimethylbenzofuransAnti-cancer AgentDerivativesBiochemistryAnalgesic AgentsPharmacological AgentGastrointestinal Safe AntiinflammatoryDrug DevelopmentPharmacologyAnti-inflammatoryNatural SciencesInitial DiscoveryMedicineDrug Discovery
We report an expansion of the scope of our initial discovery that 5-keto-substituted 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofurans (DHDMBFs) are antiinflammatory and analgesic agents. Several other functional groups have been introduced at the 5 position: amides, amidines, ureas, guanidines, amines, heterocycles, heteroaromatics, and heteroaryl ethenyl substituents in the 5 position all provide active compounds. These compounds are dual cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) inhibitors. They inhibit both COX-1 and COX-2 with up to 33-fold selectivity for COX-2.
11
Paul C. Unangst, David T. Connor, Wiaczeslaw A. Cetenko et al. · Journal of Medicinal Chemistry · 1994 · 162 citations · Full text